Search

everythinglearnresearchcommunity

for

Search:↓

Genetically at-risk healthy people show similar immune issues as those with Pemphigus vulgaris or Alopecia areata.

Tyrosinase and gp100 proteins can help diagnose and treat melanoma.

Genetic screening is crucial for accurately diagnosing APS-1 due to its varied symptoms.

Changes in genes FGA, VWF, and ACTG1 may contribute to pemphigus vulgaris.

Alopecia areata is linked to immune system differences, with specific biomarkers like CXCL9 and CXCL10 being key for diagnosis and potential treatment targets.

ADT-G may be a useful indicator of increased androgen levels in women with acne and can be lowered with certain birth control pills.

γδTregs may help treat autoimmune diseases like alopecia areata by promoting hair regrowth and reducing immune attacks.

GLI1 RNA CISH effectively identifies basal cell carcinoma but is less specific for benign follicular tumors.

Ruxolitinib significantly improves multiple autoimmune conditions in APS-1 patients.

BST2 is highly expressed in certain immune cells in alopecia areata, suggesting a role in the disease.

PAS III can cause multiple autoimmune diseases with noticeable skin issues.

Infliximab can trigger lupus-like symptoms in Crohn's disease patients.

Human hair and nail proteins are unlikely to cause allergic reactions.

Testing for various autoantibodies in Indian children with lupus can help predict disease symptoms and risks.

Mogamulizumab can cause hair loss and skin rashes.

Eating grape powder may reduce the severity of skin allergy symptoms.

Blocking interferon-gamma might help treat various autoimmune diseases.

Managing multiple autoimmune diseases in one patient is extremely challenging.

A man had a severe allergic reaction to sulfasalazine, with symptoms improving after treatment and follow-up.

Certain genetic variations in IL-16 may increase the risk of alopecia areata.

GLP-1RA therapy may increase the risk of hair loss.

Certain cytokines may cause or be affected by immune skin diseases, suggesting possible new treatments.

Timely diagnosis and treatment of complex autoimmune diseases like APS2 are crucial to prevent complications and improve life quality.

SH-SY5Y cell lysate is effective for diagnosing Satoyoshi syndrome.

Gut bacteria differences could help diagnose and treat alopecia areata.

Six months after COVID-19, most patients still had autoantibodies.

Different types of atopic dermatitis were linked to specific genetic and immune changes, suggesting that severe cases might need stronger immune-targeting treatments.

Isolated amylase deficiency can cause failure to thrive and should be checked with specific tests.